V-116517

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameV-116517
Drug Alias NameV-116517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPainNeuralgia, PostherpeticOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue PharmaShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue Pharma Lp
Active IndicationsN/A
Inactive IndicationsPainNeuralgia, PostherpeticOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A